Healthcare
Live Price
Offline$12.05
+0.00% today
1Y Change
+138.14%
Window
Jun 23, 2025 β Jun 15, 2026
Coverage: 253 bars Β· Jun 23, 2025 β Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RemeGen Co., Ltd. (REGMF) is a Healthcare stock with a market cap of $71.56B and listed on OTC. The stock last traded around $12.05 and up 138.1% across the available one-year price window (Jun 23, 2025 β Jun 15, 2026). Baseline metrics include revenue growth of +85.2%, EPS growth of +146.2%, a dividend yield of 0.0%. What stands out right now is revenue +85.2%, EPS +146.2%, free cash flow +90.3% with operating margin 28.0% and ROIC 15.5%. Valuation already assumes a fairly strong business story at P/E 56.0 and price/sales 21.2. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines REGMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
REGMF
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
REGMF Max Drawdown
-18.11%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for REGMF and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.